MoonRBRichardsJH: Determinations of intracellular pH by 31-P magnetic resonance. J Biol Chem.248: 7276–7278, 1973.
2.
HoultDIBusbySJ W: Observations of tissue metabolism using phosphorus 31 nuclear magnetic resonance. Nature252: 285–287, 1974.
3.
HenrikssonD: Magnetic resonance spectroscopy in clinical reserarchActa Radiol.35: 96–116, 1994.
4.
HuggJWDuijnJH: Elevated lactate and alkalosis in chronic human brain infarction observed by 1-H and 31-P MR spectroscopic imaging. J Cereb Blood Flow Metab.12: 734–744, 1992.
5.
LevineSRHelpernJA: Human focal cerebral ischemia. Evaluation of brain pH and energy metabolism with P-31 specroscopy. Radiology185: 537–544, 1992.
6.
GideonPHenriksenO: Early time course of N-acety-laspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke23: 1566–1572, 1992.
7.
EkholmSAronssonE Forssell: Phosphorus-31 MR spectroscopy in the pre-operative evaluation of symptomatic unilateral carotid artery stenosis. Acta Radiol.37: 288–293, 1996.
8.
NeemanMDeganiH: Metabolic studies of estrogen - and tamoxifen - treated human breast cancer cells by nuclear magnetic spectroscopy. Cancer Res.49: 589–594, 1989.
9.
NegendankWG: Studies of human tumours by MRS: A review. NMR in Biomed5: 303–324, 1992.
10.
HuggJWLaxerKD: Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Annals of Neurology34: 788–794, 1993.
